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Echocardiography may provide information concerning
the structural development of the fetal human heart. The
information available from such studies, when inter-
preted in light of existing knowledge of developmental
cardiac physiology, may give insight concerning in utero
cardiac pump function. The quantitation of cardial:
structural growth In utero has been used to provide growth
curves for the chambers of the fetal heart. Disparity in
the ratio of right ventricular/left ventricular size (nor-
mally 1.0 to 1.2) may suggest acute ventricular failure
and dilation. Electromechanical analysis using M-mode
Fetal echocardiographic studies utilizing commercially
available two-dimensional, M-mode and pulsed Doppler in-
struments have become an important adjunct to the obstetric
evaluation of high risk pregrlancies (1-4), Data concerning
cardiac structure and rhythln may be gleaned from such
studies, with successful imaging attainable between 18 weeks'
gestation and term in 90 to 95% of the cases examined.
It is the aim of this report to review the role of fetal
echocardiography as a means of assessing cardiac pump
function and the status of the fetal circulatory system in the
second and third trimester human fetus. We will review the
use of volumetric analysis of the fetal heart as well as the
timing of electromechanical events as a means of evalu-
ating cardiac performance. We will also review the use of
the fetal echocardiogram for the analysis of cardiac rhythm.
These data will be interpreted in the context of the existing
body of information that has been generated in laboratories
utilizing fetal animal models. Finally, the practical appli-
cation of these ptinciples for the analysis of hydrops fetalis,
fetal cardiac arrhythmias and fetal cardiomyopathies will be
presented. The indications for and potential problems unique
to studies in the intact fetus and the sensitivity and specificity
of these techniques will also be addressed.
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techniques may be used to analyze and monitor the treat-
ment of fetid cardiac arrhythmias and provide systolic
time interval analysis. Doppler waveform analysis pro-
vides information concerning directional flow and ~as·
cular impedance and Doppler flownietry has promise for
the Ineasurement of fetal adrtit and umbilical venous
blood flows. Such studies Have increased our under-
standing of fetal circulatory function and have practical
implications for the establishment of fetal cardiac di-
agnosis and treatment programs.
(J Am Coil Cardiol1985;5:84S-94S)
Quantitative Fetal Echocardiographic Studies
The nature of the subject under study (that is, the intact
huinlm fetus) limits our ability to manipulate the subject's
environment and, therefore, to control such variables as
preload, afterload, heart rate and myocardial inotropic state.
H is, therefore, impossible to generate the pressure-volume
data that would be necessary to characterize muscle function
().
M-mode echocardiography affords the advantage ofnipid
sampling rates and hardcopy representation of cardiac mo-
tion against time. However, simultaneous or sequential two-
dimensional imaging is necessary to define the examining
plane and the level within the heart at which the measure-
ments are obtained. The equipment currently available limits
M-mode scanning to planes that are either I'erpendlcular to
the skin's surface (linear array scanners) or along selected
planes within the "fan" of mechanically or electronically
swept sector scanners. If the heart of the fetus cannot be
approached in a manner placing the M-mode examining
plane perpendicular to the long axis of the heart, the an-
gulated view of the ventricles so obtained may introduce
considerable error in ventricular chamber measurement. In
addition, the lack of a high quality simultaneous fetal elec-
trocardiogram makes it impossible to perform end-diastolic
measurements in accordance with the standards of the Amer-
ican Society of Echocardiography, which has recommended
that end-diastole be considered the onset of the QRS com-
plex. Diastolic ventricular measurements are usually made
at the point of maximal chamber dimension, at the level of
the mitral leaflets. Measurements are made, when possible,
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when the M-mode scan has been oriented utilizing the four
chamber view of the fetal heart (Fig. I).
~oncept of "combined ventricular output." To de-
scribe cardiac output and regional organ blood flow in the
fetal Iamb. in which the ventricles function in parallel rather
than in series, the concept of "combined ventricular output"
has been developed (7). Rudolph an~ Heymann (8) dem-
onstrated that the fetal lamb ejects approximately two-thirds
of the cQmbined ventricular output from the right ventricle.
The one-third of combined output that is ej~cted from the
left ventricle is distributed predominantly to tpe heart, brain,
upper trunk and forelimbs. The disparity between right and
left ventricular o~tputs is less marked in t~e human fetus,
in which the brain receives a considerably higher percent
(= 15 to 20%) of the combined ventriclliar output than the
approximately 3% it receives in the fetal lamb (9). In ad-
dition, change in the relative blood flow distributed to the
brain of the human fetus during late gestation aHers the
relative right and left ventricular volumes over the course
of development.
This relative "volume overload" of the fetal right ven-
tricle may have an important influence on efforts to perform
volumetric studies of th~ fetal heart.
Pre- versus postnatal v~ntricular shaPf. In 1972.
Winsberg (10), using M-mode echocardiography, applied
geometric formulas to convert left ventricular linear dimen-
sions to ejection fraction, ~troke volume and cardiac output
Figur~ 1. Simultaneously recorded tWQ-dimensioral anq M-mode
echocardiographic stpdy in a 32 week old fetus. The M-mode scan
is recorqed at the level of the milral valve. The M-mode "cursor"
is perpendicular to the plane of the interventricular septum (long
arr9w). The right ventricular cavity (RY) (small arrow) dimen-
sion (15 mm) exceeds that of the left ventricle (LY) (small arrow)
(12 111m) by a ratio of 1.2. The interventricular septal (open arrow)
motion is flat.
determination in the human fetal heart. The formulas used
were based on a geometric model assuming the left ventricle
to resemble, as in the postnatal state, a prolate ellipse.
Although this report represented the first effort to generate
such data in the intact human fetus, these calculations may
have been flawed by the assumption that the fetal left ven-
tricle has the same shape that it will assume postnatally.
We have noted (1) flattened or paradoxic interventricular
septal motion in mor~ than one-half of the fetal studies
performed d!lring the midportion of the third trimester. This
observation has suggested that the right ventricle of the
human fetus, like that the fetal lamb, is relatively volume
"overloaded. " This results in end-diastolic displacement of
the interventricular septum into the left ventricle. The latter
finding has been svbsequently confirmed in our two-dimen-
sional studies of fetal cardiac structure. This produces a
relative "flattening" or "pah~aking"of the left ventricular
cavity. Azancot et al. (11), using short-axis two-dimen-
sional fetal scans, noted the same "flattening" of left ven-
tricular contour during diastole. They observed less distor-
tion of the left ventricle imQlec!iately postnatally and even
less in the 3 month old infant. All of these data suggest that
the fetal human heart, like that of the fetal lamb, has a larger
right to left ventricular volume nitio in utero than it does
postnatally. In addition, geometric models of left ventricular
shape that are of use in determining ventricular volumes
postnatally may be inaccurate when applied to the fetus.
AHan et al. (12) and Wladimiroff et a1. (13,14), using M-
mode echocardiography, demonstrated right and left ven-
tricular transyerse dim~nsions that are approximately equal
between the 16th and 40th weeks of gestation. Although
Allan et al. did not study these fetuses postnatally, the data
of WladiqJ.irQff et al. show an immediate alteration in the
ratio of right to left ventricular dimension from 1.0 to 0.6
within 10 minutes of delivery. These data support the con-
cept of relative right ventricular dilation in utero. Our data
are in closer agreement with those of Sahn et al. (15), who
found a prenatal rigpt ventricular/left ventricular ratio of
I. 18 ± 0.0 I compared with 0.99 ± 0.03 within 36 hours
of birth.
In the fetal heart, alterations in ventricular output may
alter the relative sizes of the ventricular cavities. This may
be associated with either structural or functional derange-
ments. We encountered marked left ventricular dilation in
an hydropic fetus who was subsequently diagnosed to have
a left ventricular infarction (16). In contrast acute right
ventricular dilation was encountered in two fetuses with
"idiopathic fetal hydrops" and may be found in preterminal
fetuses with severe intral.lterine growth retardation and pla-
cental insufficiency (Fig. 2). The increased disparity in ven-
tricular dimensions may result from an acutely increased
afterload in the placental circulation. Increased impedance
to right ventricular ejection results in acute right ventricular
failure and dilation. This finding has a correlate usillg fetal
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Figure 2. Simultaneously recorded two-dimensional and M-mode
echocardiographic study in an hydropic. growth-retarded 32 week
fetus. There is a large pleural effusion (Ef). The right ventricular
(RV) cavity dimension (16 mm) exceeds that of the left ventricle
(LV) (arrow) (9 mm) by a ratio of 1.8. Cardiac configuration was
normal.
animal models, in which acutely increased afterload on the
right ventricle, accomplished by inflation of a balloon in
the descending aorta, produced a decrease in right ventric-
ular output and fetal heart rate (8). This suggests that eval-
uation of right ventricular dimension and relative ventricular
size may be used as a barometer of fetal circulatory function
(Fig. 3). We are currently investigating the use of a two-
dimensional model of the combined ventricular mass as a
means of assessing fetal cardiac pump function. Our efforts
have been hampered by the low sampling rates of current
two-dimensional imaging equipment and the difficulties in-
herent in storing this information for later retrieval from
video tape recorders, which are poorly suited for analysis
of volume changes in the rapidly beating fetal heart.
Systolic Time Intervals
In recent years, perinatologists have attempted to assess
the well-being of human fetuses through examination of fetal
cardiac electromechanical time intervals using Doppler
ultrasound (17). Cardiologists have used systolic time in-
terval measurements computed from external pulse and
phonocardiographic and electrocardiographic recordings (18)
and, more recently, from M-mode echocardiographic re-
cordings of semilunar valve opening and closure (19,20) as
a noninvasive technique for the evaluation of systolic ven-
tricular performance and vascular impedance. Simply stated,
the systolic time intervals consist of the pre-ejection period
and the ventricular ejection time. The pre-ejection period
consists of the electromechanical delay (the onset of the
QRS complex to the onset of ventricular contraction) and
the isovolumic contraction period (the onset of ventricular
contraction to semilunar valve opening). The ventricular
ejection time is the period between semilunar valve opening
to valve closure. The duration of these intervals depends on
five factors: preload, afterload, contractile state of the myo-
cardium and the rate and sequence of intraventricular elec-
trical conduction.
We developed a technique for the measurement of sys-
tolic time intervals in the human fetal heart (21). Studies
were performed on fetuses between 22 and 42 weeks' ges-
tation, using M-mode echocardiographic recordings of fetal
semilunar valves, and simultaneously inscribed fetal electro-
cardiographic signals that were obtained utilizing electrodes
placed on the maternal abdominal wall. Because the electro-
cardiographic channels supplied with commercially avail-
able echocardiographs do not have sufficient gain to detect
Figure 3. Simultaneously recorded two-dimensional
and M-mode echocardiographic study in a 20 week old
fetus. This fetus had massive right atrial enlargement.
right ventricular (RV) dilation (II mm), tricuspid valve
dysplasia and pulmonary atresia. The right ventricular
dimension exceeds that of the left ventricle (LV) (6
mm) by a ratio of 1.8. Arrows connect corresponding
structures in two-dimensional and M-mode tracings.
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Figure 4. Left ventricular systolic time intervals
measured from simultaneously inscribed M-mode
echocardiogram of aortic valve motion and electro-
cardiogram showing maternal (M) and fetal (F) QRS
complexes. The pre-ejection period (PEP) is mea-
sured from the onset of fetal electrical activation to
+-t--t-+-+-..=- aortic valve opening. The left ventricular ejection
time (LVET) is measured from semilunar valve
opening to closure.
M
the fetal signal, a preamplifier was used. The signal was
processed through a low frequency filter.
The pre-ejection period was measured from the point of
onset of the fetal QRS complex to the opening of the sem-
ilunar valves. The ejection times of the two ventricles were
measured from the point of opening to the closure of their
respective semilunar valves (Fig. 4). The ratio of pre-ejec-
tion period/ventricular ejection time was independent of heart
rate, but was positively correlated with gestational age (Fig.
5A). The latter finding was due to a lengthening of pre-
ejection period with a negligible change in ventricular ejec-
tion time. In studies of the fetal lamb, Organ et al. (22)
observed a prolongation of pre-ejection period with cord
occlusion. This was attributed to an acutely increased af-
terload and a decreased preload. Human fetal studies uti-
lizing Doppler techniques have similarly shown prolonga-
tion of the pre-ejection period associated with cord
compression.
Some studies have suggested that stressed and hypoxic
fetuses may actually have a shortened pre-ejection period
(23). This has been attributed to an enhanced inotropic state
associated with a stress-related release of catecholamines.
If this is true, it may be expected that further study will
show a variable pre-ejection period response at varying ges-
tational ages, depending, in part, on the level of develop-
ment of sympathetic innervation. Animal studies (8) have
demonstrated a great interspecies variation in the time of
appearance of sympathetic innervation of the heart. In the
lamb, innervation is present at 0.6 gestation and well de-
veloped at term (24). The level of development of sym-
pathetic innervation in the human fetus is not certain, but
developmental changes in the degree of innervation may be
expected to alter cardiac responsiveness to stress at different
gestational ages.
We have encountered a fetus at 27 weeks' gestation with
hydrops fetal is , polycystic kidneys and no evidence of struc-
tural heart disease. There was marked right heart dilation
with pericardial effusion. Markedly abnormal systolic time
intervals were noted. The pre-ejection period was nearly
twice the expected value (100 versus 55 ms), with a short-
ened left ventricular ejection time. The pre-ejection pe-
riod/left ventricular ejection time ratio (0.9) was nearly three
times the predicted value for this gestational age (0.22 to
0.35) (Fig. 58). This finding is consistent with our hy-
pothesis that nonimmune hydrops fetalis represents end-
stage congestive heart failure in utero.
The use of M-mode echocardiography, with spatial ori-
entation of the transducer beam utilizing a simultaneous or
sequential two-dimensional scan, allows these measure-
ments to be performed with correct identification of the
semilunar valves involved (21). Although one might expect
the ejection times of the two ventricles to be simlar because
of the nonrestrictive ductus communication in utero, it has,
in fact, been found that the ejection times of the two ven-
tricles differ from one another. Nisand et al. (25) found the
left ventricular ejection time to exceed the right ventricular
ejection time. In four cases in which pulmonary and aortic
valves were recorded simultaneously in our laboratory, right
ventricular ejection time exceeded left ventricular ejection
time (Fig. 6). These findings are compatible with a greater
volume ejection from the right ventricle. Further study will
be necessary to reconcile these disparate findings, which
may be attributable to our small sample or may be a function
of the earlier gestational ages in our sampling (as early as
22 weeks) compared with those in the study of Nisand et
al. (32 to 42 weeks) and the alteration in relative ventricular
volumes later in human gestation as brain flow increases.
Although while promising as a means of assessing pump
function, fetal systolic time interval measurements are dif-
ficult to obtain, largely because of the low (50 to 60%)
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success rate in recording adequate transabdominal fetal elec-
trocardiograms against the background interference from the
maternal electrocardiograms.
Figure 5. A, The ratio pre-ejection period/left ventricular ejection
time (PEP/LVET) is independent of heart rate but directly corre-
lated to gestational age. D, The PEP/LVET was grossly elevated
(0.9) in a severely hydropic 27 week old fetus. 0, data points;
., !'1, 0, 95% confidence limits.
Postextrasystolic Potentiation
We have investigated the ability of the human fetal heart
to manifest postextrasystolic potentiation to determine whether
the fetal heart can modulate its contractile state. Although
previous animal studies have suggested that the fetal lamb
heart exhibits postextrasystolic potentiation (26,27), it has
been suggested that such potentiation is limited in the human
neonate (28). Little evidence exists concerning whether this
property exists in the human fetus (29).
We have analyzed M-mode echocardiographic tracings
of human fetal hearts between 32 and 37 weeks' gestation
in which spontaneously occurring isolated atrial or ventric-
ular extrasystoles were documented. Measurements of right
and left ventricular chamber size, shortening fraction and
wall thickness were evaluated as was peak systolic wall
velocity (the latter was measured because it is an index
independent of ••geometric assumptions" concerning ven-
tricular shape) at baseline and during the first postextrasys-
tolic beat. Our findings were compatible with the presence
of postextrasystolic potentiation in the human fetus. Al-
though we are unable to state whether this is due to increased
preload, decreased afterload or enhanced contractility (per-
haps calcium-mediated), it suggests that the human fetus
can modulate its contractile state in a manner that is mea-
surable using fetal echocardiography. Although this may
Figure 6. Simultaneously inscribed M-mode echocal ~._~.~==:~:ill~~~~~;;;;~~~;! -====diograms of pulmonary (PA) and aortic (AD) valve~ :;;; =:
Pulmonary and aortic valve opening (Po and Ao, f( •
spectively) were simultaneous, whereas pulmonar
closure (Pc) occurred later than aortic closure (Ae).
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have some potential for monitoring in utero antiarrhythmic
therapy in a setting where spontaneous extrasystoles are
common, these measurements are of limited practical use
as a screening technique because of the rarity and unpre-
dictable occurrence of spontaneous extrasystoles in the fetal
heart, In addition, the site of origin (atrial versus ventricular,
right-sided versus left-sided) of the extrasystoles could alter
preload substantially and thereby influence the presence and
degree of potentiation of ventricular contraction.
Doppler Flow Studies
The techniques described do not provide information con-
cerning fetal cardiac flow. This information may be attain-
able using the newer techniques of pulsed and continuous
wave Doppler flowmetry. The initial experience with these
techniques is encouraging (30-32) because flow estimates
have been both reproducible and quantitatively similar to
the flows that have been reported (33,34) (descending aortic
flow 185 to 261 ml.min-I.kg- I ; umbilical venous flow 115
ml.min - I.kg - I) using other measurement techniques. The
potential errors in Doppler measurement techniques are,
however, substantial. These are easily explained by ex-
amining the standard form of the Doppler equation for quan-
tifying flow:
fDcv=--
2focosO '
where V = velocity, fD = output of the mean frequency
demodulator; c = velocity of ultrasound in blood (1,570
m/s); cos = cosine; fo = operating frequency and 8 =
angle between insonating beam and vessel. The blood flow
(Q) is then calculated from V according to the equation:
where d is the diameter of the vessel.
For any small error in measurement of the angle 8, the
cos 8 term will be altered very little for small angles (8 <
30°). If the insonating beam approaches the blood vessel
being studied at an angle greater than 45 to 60°, however,
a small error in measurement of 8 will result in a large error
in the cos 8 term and, therefore, impart a large error in the
calculation of velocity. In the active fetus it may be difficult
to insure a consistent incident angle of less than 45°. In
addition, any error in measurement of vessel diameter (d),
either due to vessel pulsation, lack of clear def..nition of
lumen boundary or tangential view of the vessel lumen , will
again impart substantial error. In vitro tests in vessels rang-
ing from 0.5 to 1.5 mm in diameter and insonating angles
less than 45° have resulted in average accuracies of 85% in
flow calculations (35). Further in vitro and in vivo exper-
iments analyzing errors introduced by inaccurate vessel
measurement suggest that such errors can be held below
10%. Hence, Doppler flow studies hold great promise for
the analysis of umbilical and aortic flow. In the absence of
quantitative flow estimates, Doppler waveform analysis may
provide valuable information concerning directional flow
within the heart and blood vessels and may detect valvular
insufficiency, absent, decreased or reversed foramen ovale
shunting and altered flow patterns associated with fetal
arrhythmias.
Fetal Cardiac Rhythm
Disturbances of fetal cardiac rhythm are usually first sus-
pected on the basis of auscultatory findings. Because of the
inability of transabdominal electrocardiography to distin-
guish atrial depolarization, this technique is of limited value
for the analysis of in utero cardiac arrhythmias. Utilizing
M-mode recordings of cardiac motion against time, we have
drawn (36) conclusions regarding electrical events in the
fetal heart as they are reflected by the mechanical responses
that are recorded echocardiographically. Our technique in-
volves registration of M-mode tracings of atrioventricular
valve motion, atrial and ventricular wall contraction se-
quence and interventricular septal motion. Scans are located
on the fetal heart using a simultaneously inscribed two-
dimensional image. These techniques provide a noninvasive
means of diagnosing rhythm disturbances in the fetal human
heart, and monitoring efforts at transplacental antiar-
rhythmic therapy (Fig. 7).
Supraventricular tachyarrhythmia. We have encoun-
tered 13 cases of sustained supraventricular tachyarrhythmia
during the past 3 years. These have included nine cases of
supraventricular tachycardia, three cases of atrial flutter and
one case of atrial fibrillation. Ten of the 13 fetuses had
associated hydrops fetalis. Utilizing the M-mode fetal echo-
cardiogram, the tachycardia was documented. Ventricular
anatomy and dilation were assessed and pericardial effusions
were identified. Transplacental therapy through maternal
administration of antiarrhythmic agents, including digoxin,
verapamil, propranolol and procainamide, was monitored
echocardiographically. With these agents alone or in com-
bination, eight of the nine fetuses with supraventricular
tachycardia were successfully treated transplacentally and
delivered as normal healthy infants at term. The ninth fetus
was delivered by cesarean section at 34 weeks' gestation
after an unsuccessful effort at arrhythmia control with di-
goxin and propranolol therapy. The neonate eventually did
well, but only after a harrowing neonatal period that in-
volved respirator management of hyaline membrane disease,
multiple thoracenteses and paracenteses for control of tense
ascites and pleural effusions and multiple episodes of elec-
trical cardioversion. Since that experience, we have em-
ployed verapamil in combination with digoxin for control
of in utero supraventricular tachycardia in three patients.
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The fetal echocardiogram was used to monitor the fetal
response to therapy.
Bradycardia. The sudden onset of severe bradycardia
secondary to complete or high grade second degree heart
block may be associated with hydrops fetalis due to the
sudden increase in ventricular diastolic dimension associated
with the bradycardia. In the presence of the noncompliant
fetal ventricle (24), the increased volume is associated with
a marked increase in end-diastolic pressure. In such cases,
we recommend consideration of early delivery and pace-
maker management. Early in gestation, with pulmonary im-
maturity, we would focus efforts on increasing heart rate,
possibly through the administration of beta-adrenergic
agents to the mother (for example, isoproterenol or Rito-
drine). Ritodrine, if associated with improved fetal status
as demonstrated by decreased ventricular dimension and
resolution of hydrops fetalis, could be chronically main-
tained in an oral form.
Isolated versus sustained arrhythmia. Our initial stud-
ies are consistent with those of other investigators (37) who
have suggested that isolated ventricular or atrial extrasys-
toles are of little or no hemodynamic consequence and that
most will spontaneously resolve later in pregnancy or during
the first days of life. Follow-up study may be indicated,
however, because of the possibility that an extrasystole may
occur at a coupling interval that will incite a sustained reen-
trant tachycardia. We have experienced one such occurrence.
We have found that sustained arrhythmias, when asso-
ciated with severe congenital cardiac malformations (te-
tralogy of Fallot in one case and an atrioventricular septal
defect in another) have a poor prognosis, and both of these
hydropic fetuses died in the neonatal period.
Figure 7. M-mode echocardiogram in a 32 week old fetus with
supraventricular tachyarrhythmia. Motion of left ventricular (LV)
posterior wall (curved arrows) suggests an irregular ventricular
response caused by a variable atrioventricular block. Rapid un-
dulations reflecting atrial flutter rate of 480 beats/min are reflected
on the atrioventricular valves (vertical arrows). This echocardio-
gram was recorded after administration of digoxin and verapamil
to the mother of the fetus.
Limitations of echocardiography in diagnosing fetal
arrhythmia. The use of the echocardiogram to delineate
electrical events in the fetal heart is not without its diffi-
culties. We recently encountered in a diabetic mother a fetus
with evidence of hypertrophic cardiomyopathy and pro-
tracted episodes of sustained tachycardia at approximately
200 beats/min. During episodes of sustained tachycardia,
the fetus developed gasping respirations at a rate of 80 to
100 breaths/min. This was interpreted as evidence of fetal
distress (38). Amniocentesis was performed, demonstrating
evidence of inadequate pulmonary surfactant production.
Efforts were made to "treat" the arrhythmia with transpla-
centally administered digoxin. This was maintained throughout
the last 6 weeks of pregnancy with in-patient echocardio-
graphic monitoring of cardiac size, rhythm and respiratory
pattern. The gasping resolved and the frequency of episodes
of tachycardia diminished. Soon after birth of a well infant
with hypertrophic cardiomyopathy, this child developed
sustained ventricular tachycardia at approximately 160
beats/min. This arrhythmia was associated with retrograde
atrial activation. During the tachycardia, echocardiograms
showed a regular relation between atrial and ventricular
activity, demonstrating the weakness of echocardiography
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for distinguishing ventricular tachycardia without atrioven-
tricular dissociation from supraventricular tachycardia. Al-
though this newborn infant did quite well on quinidine ther-
apy, potential harm could have resulted from the digitalis
administration, showing the need for close continued mon-
itoring of these patients and also demonstrating that admin-
istration of these medications in the absence of clear-cut
evidence of fetal congestive heart failure may not be jus-
tifiable using a risk/benefit analysis.
Hypertrophic Cardiomyopathy in the Infant
of the Diabetic Mother
The diabetic pregnancy represents a unique situation.
These fetuses are at risk for hypertrophic cardiomyopathy,
thought to be secondary to the chronic fetal hyperinsuli-
nemia mounted in response to chronic maternal hypergly-
cemia (39). This hypertrophic myopathy, which is usually
found in association with gross fetal macrosomia, may place
the neonate in jeopardy, as a result of either dynamic ven-
tricular outflow tract obstruction or severe restriction to ven-
tricular filling. This myopathy has been encountered in a
stillborn second trimester fetus and has also been diagnosed
echocardiographically during the midportion of the second
and during the third trimesters of pregnancy. Experience
with neonates with this cardiomyopathy has demonstrated
that children who survive the neonatal period will gradually
recover, with spontaneous resolution of the condition.
Our experience with fetuses with hypertropic myopathy
in utero has been limited to three cases (Fig. 8). One of
these cases was encountered during the second trimester in
a fetus whose mother's diabetes was poorly controlled. The
myopathy gradually improved as diabetic control improved
later in gestation. Free wall and interventricular septal thick-
ness actually diminished during later gestation and were
within normal range by the time of birth. A survey of 50
women with diabetes enrolled in our high risk obstetric clinic
showed no difference in fetal cardiac dimensions or wall
thicknesses when compared with control fetuses at similar
gestational ages and estimated fetal weights (40). It has been
suggested (41), and our clinical experience supports this
hypothesis, that fetal macrosomia and hypertrophic myopa-
thy are a function of the adequacy of blood sugar control
of the diabetic mother rather than representing a function
of duration of the diabetic state before pregnancy. There-
fore, we have looked on fetal echocardiographic evalution
of cardiac structure in fetuses of diabetic mothers as a means
not only of detecting possible structural heart disease in the
fetus, but also as a means of assessing the adequacy of
diabetic control.
Limitation offetal studies. We have been successful in
obtaining fetal cardiac images in 95% of cases studied be-
tween 18 and 40 weeks' gestation in nondiabetic mothers.
Our higher failure rate with diabetic mothers has been ac-
counted for primarily by difficulties inherent to studies at-
tempted on obese mothers, in whom the fetal heart is so far
Figure 8. Simultaneously recorded two-di-
mensional and M-mode echocardiographic
study in a 32 week old fetus of a diabetic
mother. The thickness of the interventricular
septum (lVS) (7 mm) is consistent with hy-
pertrophic cardiomyopathy. LV = left ven-
tricle; RV = right ventricle.
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from the maternal abdominal wall that lower frequency (2.25
MHz) ultrasound is required to attain adequate tissue pen-
etration (we prefer to use 3.0 to 5.0 MHz sources). At the
lower frequency range, spatial resolution may be too poor
to allow adequate fetal cardiac study. Unfortunately, ma-
ternal obesity is frequently encountered in diabetic mothers,
resulting in a much higher (30 to 40%) failure rate of study
in this group.
Nonimmune Hydrops Fetalis
Fet<\1 echocardiographic studies in fetuses wIth nonim-
mune hydrops have given information that may be put to
practical use in the management of these offspring. With
the declining frequency of Rh isoimmunization in the west-
ern world, nonimmune hydrops fetalis has become the pre-
dominant form of hydrops encountered by perinatologists.
Previous reports (42) have indicated that mortality rates from
this condition approximate 100%. The contribution of non-
immune hydrops to total perinatal mortality has increased
over a 10 yeflr period from 0.1 to 3% (43). Although a large
number of fetal abnormalities may result in hydrops fetalis,
we and, more recently, others (16) have noted a large pro-
portion of cases of nonimmune hydrops to have an identi-
fiable cardiovascular explanation for "heart failure" and
resulting systemic edema. The fetal echocardiogram has
been useful in identifying these causes of circulatory
decompensation.
Pathophysiology. The underlying pathophysiologic
mechanism appears to be related to acute volume or pressure
overload, or both, of the fetal right atrium with subsequent
development of systemic venous hypertension. Due to the
parallel flow cicuits within the fetal heart and the commu-
nication at the level of the foramen ovale, acute alterations
in the filling characteristics of either fetal ventricle will cause
an alteration in right atrial emptying. Data from the study
of fetal lamb hearts suggest decreased compliance in the
fetal ventricie compared with neonatal and adult ventricles
due to a relative paucity of contractile elements in the fetal
myocardium. There is also a more marked influence in utero
of diastolic hypertension in one ventricle on the filling char-
acteristics of the contralateral ventricle (24). For these rea-
sons, a variety of cardiac malformations, including those
associated with semilunar valve or atrioventricular valve
regurgitation, functional abnormalities (myocarditis), mass
lesions or sustained tachyarrhythmias may result in systemic
venous hypertension and systemic edema. We noted severe
hypoalbuminemia « I g/dl) in two hydropic neonates with
cardiac causes of hydrops (one with supraventricular tachy-
cardia, one with an embolic left ventricular infarction). We
believe that the hypoalbuminemia is due either to hepatic
dysfunction secondary to severe systemic venous hyperten-
sion or to loss of albumin through the intestine, lungs or
into third-spaced fluid. We have found pericardial effusions
in 12 of the first 13 hydropic fetuses scanned and now
consider pericardial effusion, especially in the presence of
a sustained arrhythmia or ventricular chamber dilation, to
be a harbinger of hydrops fetalis (44).
Role of early identification. We believe that it is im-
portant to identify specific causes of hydrops fetalis as early
as possible during gestation in an effort to identify cases
that could potentially be treated in utero. In a recent review
of hydrops, Hutchison et al. (45) stated that the most con-
sistent sequela of hydrops, occurring in more than 90% of
cases, was pulmonary hypoplasia, presumably related to
compression of the developing lung tissue by pleural ef-
fusions. This potentially fatal complication may be avoided
if reversible causes of hydrops fetalis are identified and
treated in utero and if, in selected cases, the child is deliv-
ered early, before the development of large pleural effu-
sions. We, therefore, have advocated the use of fetal echo-
cardiography as an adjunct to the obstetric ultrasound
examination in evaluating the fetus with nonimmune hy-
drops. Because the condition of some hydropic fetuses rap-
idly worsens to an irreversible state, we recommend the
expeditious ultrasonic evaluation of all pregnant women
presenting with polyhydramnios (found in 74% of mothers
with hydropic fetuses), pre-eclampsia (34% of mothers with
hydropic fetuses) or a sudden decrease in fetal activity.
Conclusion
The grossly hydropic fetus represents the most serious
manifestation of disordered pump function. The finding of
disproportionate ventricular enlargement, pericardial effu-
sion in the absence of generalized edema and other serous
effusions, abnormal ventricular systolic time interval mea-
surements, cardiac arrhythmias heralding the onset of sus-
tained tachyarrhythmia (for example, frequent extrasystoles
associated with short episodes of nonsustained supraven-
Table 1. Indications for Fetal Echocardiography
Fetal factors
Intrauterine growth retardation
Fetal cardiac arrhythmia
Fetal somatic anomalies (ultrasound)
Hydrops fetal is
Abnormal genetic screen
Decreased fetal movement
Maternal factors
Congenital heart disease
Polyhydramnios
Rh sensitization
Diabetes mellitus
Collagen vascular disease
Drug exposure (alcohol, anticonvulsants, lithium, etc.)
Pre-eclampsia
Familial factors
Congenital heart disease
Genetic syndromes
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tricular tachycardia) or complete heart block (for example,
second degree atrioventricular block in a fetus whose mother
has systemic lUpus erythematosus) are alarming and should
be viewed as harbingers of more disordered circulatory func-
tion. If these signs are scrupulously sought. the sensitivity
of fetal echocardiographic analysis for detecting functional
disorders of the fetal circulatory system will be further
improved.
These studies can be performed using commercially
available echocardiographic equipment. Each examination
requires approximately 30 to 40 minutes for completion.
Unfortunately, it would be a prodigious and cost-ineffective
undertaking to recommend routine ultrasound examination
of every pregnant woman, although this approach is being
made in some European centers. Despite the absence of any
hard data to suggest the detrimental effect of ultrasound at
these frequencies and energy levels either on the mother or
offspring, we maintain that discretion dictates reserving such
study for women whose fetuses are "at risk" for structural
or functional heart disease (Table 1).
Fetal cardiac ultrasound studies have increased our un-
derstanding of normal and abnormal cardiac development
in the human fetus. As a means of detecting abnormalities
in cardiac structure and function and by providing a tech-
nique for monitoring our efforts at in utero treatment. the
fetal echocardiogram has provided the cornerstone for the
development of the first fetal cardiac diagnosis and treatment
programs.
We thank Norman S. Talner, MD and John e. Hobbins, MD for encour-
agement and support, Diana e. Lynch, RN for technical expertise and
Mary Beth Graham for secretarial skills.
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